Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database
Abstract Introduction Poor persistence to biologics can result in suboptimal health outcomes and increased economic burden for chronic conditions, including psoriasis (PsO). In Japan, studies evaluating factors responsible for biologic treatment persistence in patients with PsO are limited. We asses...
Saved in:
Main Authors: | Celine Miyazaki (Author), Junya Masuda (Author), Phiona I-Ching Tsai (Author), Hidehisa Saeki (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan
by: Celine Miyazaki, et al.
Published: (2024) -
Real‐world treatment patterns of patients with atopic dermatitis in Japan: Analysis of the JMDC Claims Database
by: Kazumasa Kamei, et al.
Published: (2021) -
Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan
by: Teppei Hagino, et al.
Published: (2024) -
Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databasesCapsule Summary
by: Steven R. Feldman, MD, et al.
Published: (2024) -
Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
by: Teppei Hagino, et al.
Published: (2024)